BlackDoctor Pro is launching Wellbot, a new AI-powered clinical simulation tool that allows healthcare professionals to practice real-world patient interactions in an immersive environment.
The first simulation focuses on multiple myeloma, a blood cancer that disproportionately affects Black Americans, who account for 20 percent of multiple myeloma cases.
Developed with input from medical experts and Black hematologist-oncologists, the Wellbot challenges clinicians to identify subtle signs of multiple myeloma while practicing patient-centered care and shared decision-making.
Modern cancer care is increasingly complex. There are rapid advancements in targeted therapies, genomic diagnostics, and specialized treatment sequences that go beyond traditional chemotherapy and radiation.
The expansive treatment landscape has turned patient communication into a balancing act for many clinicians. While breakthroughs have significantly improved outcomes, they have also increased the volume and intricacy of information that a clinician must convey to patients.
Conversations about cancer treatment can be difficult for many patients – especially those from underserved communities. Delivering clear, culturally responsive information can be critical for building patient trust and supporting treatment adherence.
“It is really difficult, if not sometimes impossible, to course correct in front of a patient,” said Craig Cole, MD, a hematologist and a BlackDoctor Medical Advisory Board member. “If I’m unable to translate a T-cell redirection therapy to a patient and explain it in patient terms, then that hurts the trust between the patient and me.”
The Wellbot gives clinicians an opportunity to practice these conversations before having them with real patients.
“With the Wellbot, I can course correct and learn from my mistakes, but most importantly, I can rehearse and get feedback on that,” Dr. Cole said.
Unlike traditional medical education programs where clinicians may watch a video or complete a quiz, Wellbot delivers an interactive experience where users can interview and engage with a virtual patient. At the end of the exercise, users receive immediate, personalized feedback that can be applied in real-world clinical practice.
Another benefit of the AI simulation tool is that it’s available at any time, giving clinicians the flexibility to work on cases on their own time.
“To have the Wellbot — which is ready to go rain or shine — it will work 24/7, working around your schedule,” Dr. Cole said.
Wellbot was designed to help clinicians navigate patient encounters that reflect the diversity of the communities they serve. By allowing users to interact with Black patients, the platform supports stronger communication, greater cultural competency, and more effective shared decision-making. This approach aligns with BlackDoctor Pro’s mission of improving healthcare outcomes in underserved communities.
“You can gain that comfort and competency by interacting in a safe space with a patient of a different race, and that’s incredibly valuable because it’s a no-judgment space,” Dr. Cole said.
Multiple myeloma is the first of several Wellbot experiences planned for BlackDoctor Pro. Future simulations will explore additional therapeutic areas where disparities in diagnosis, treatment, and outcomes continue to affect underserved populations. The goal is to give healthcare professionals accessible, practical tools that improve patient communication, diagnostic confidence, and culturally responsive care.
“What makes this program special is that it was created specifically for the healthcare professionals who serve our community,” said Stephen O’Brien, Chief Product Officer at BlackDoctor. “It wasn’t built for the general market. It was designed with our audience in mind.”
By subscribing, you consent to receive emails from BlackDoctor.pro You may unsubscribe at any time. Privacy Policy & Terms of Service.
Are you a healthcare professional? Register with us today!
